High Growth Reported for the Women’s Health Diagnostic Testing
Reportlinker.com announces that a new market research report related to the Healthcare industry is available in its catalogue.
Women’s Health Diagnostic Testing
The purpose of this TriMark Publications report is to describe the specific segment of the in vitro diagnostics (IVDs) market called women’s health testing. This study includes contemporary and generally accepted clinical and analytical activities. This analysis examines clinical measurement devices, as well as their reagents and supplies, as utilized in hospitals, clinics and doctor’s offices. Some diagnostic tests, which are marketed primarily as over-the-counter products, are included in this report.
This report also includes other important tests like mammography, (i.e., tests which are not generally associated with IVD tests, but which are an important component of the overall women’s health market).
This study deals with analysis related to the common chemical constituents of blood, plasma or serum of concern to patient testing in the field of women’s health. Emphasis is on those companies and products that are actively developing and marketing clinical laboratory instrumentation, reagents and supplies for performing diagnostic tests related to women’s health. This study concentrates on the women’s health testing market segment in important worldwide markets such as the U.S., Japan and Europe.
1.0 Overview 1.1 Statement of Report 1.2 Scope of this Report 1.3 Methodology 1.4 Executive Summary 2.0 Introduction - Sector Overview 2.1 Global Diagnostic Products Industry 3.0 Women's Health Testing Market Analysis in Size, Growth and Share 3.1 Global Women's Health Testing Markets 3.1.1 Market Drivers in the Women's Health Diagnostics Testing Sector 188.8.131.52 Market Segments for Women's Health Testing 184.108.40.206 Key Players in the Women's Health Diagnostics Testing Segment 220.127.116.11 Women's Health Testing Sector Analysis 3.2 U.S. Women's Health Testing Market 3.2.1 Market Overview 3.2.2 Diagnostic Test Categories 3.3 European Women's Health Diagnostic Test Market 3.3.1 German Women's Care Diagnostic Market 3.3.2 U.K. Women's Care Testing Diagnostic Market 18.104.22.168 U.K. Market Statistics 22.214.171.124 U.K. Competitive Analysis 126.96.36.199 U.K. Market Access 3.3.3 French Women's Care Diagnostic Market 3.3.4 Italian Women's Care Diagnostic Market 3.3.5 Spanish Women's Care Diagnostic Market 3.4 Japanese Women's Care Testing Market 3.5 Chinese Women's Care Market 3.6 Rest of the World Women's Care Testing Market 4.0 Women's Health Testing Individual Markets 4.1 Pregnancy Testing 4.2 Osteoporosis Testing 4.2.1 In Vitro Blood Tests 4.2.2 Bone Densitometry Devices 4.3 Prenatal Screening Testing 4.3.1 Cystic Fibrosis 4.3.2 Prenatal Genetic Testing 4.3.3 Fragile X Syndrome 4.3.4 Tay-Sachs Disease 4.4 Fertility Testing 4.5 Breast Cancer 4.5.1 CA 15-3 4.5.2 CA 27-29 4.5.3 BRCA1 Breast and Ovarian Cancer Gene 4.5.4 BRCA2 Breast Cancer Gene 4.5.5 Tissue polypeptide antigen (TPA) 4.5.6 DNA Ploidy and S-phase Fraction 4.5.7 Estrogen and Progesterone Receptor (ER and PR) 4.5.8 HER-2 4.5.9 HER-2 and Herceptin 4.5.10 p53 4.5.11 NMP66 4.5.12 Mammastatin 4.6 Ovarian Cancer 4.6.1 CA 125 II(TM) 4.6.2 Steroid Hormone Receptors 4.6.3 Epidermal Growth Factor Receptor (EGFR) 4.6.4 HER-2/neu 4.6.5 P53 Tumor Suppressor Gene 4.6.6 Lysophospholipids 4.7 Cervical Cancer 4.7.1 Pap Smears 4.7.2 Human Papillomavirus (HPV) Testing 4.8 Miscellaneous Testing 4.8.1 Estriol 4.8.2 Fetal Fibronectin (fFN) 4.8.3 Vaginal pH and Vaginitis 4.9 Human Immunodeficiency Virus (HIV) 4.10 Infectious Disease Testing 4.10.1 Strep Testing 4.10.2 Chlamydia 4.10.3 Methicillin-Resistant Staphylococcus Aurea (MRSA) 4.10.4 Hepatitis 4.10.4 Gonorrhea 4.10.5 Urinary Tract Infections 4.11 Infant Jaundice 5.0 World Mammography Market 5.1 Mammography Overview 5.2 Market Overview 5.2.1 Introduction 5.2.2 World Mammography Markets Revenue 5.2.3 Mammography Markets by Region 5.2.4 Total Market Share 5.2.5 Competitive Structure 5.3 Market Opportunities 5.3.1 Resource Management for Mammography Markets 5.3.2 Movement to Higher Reimbursement Rates 5.3.3 Market Benchmarks for Increased Mammography Utilization 5.4 Market Analysis 5.4.1 Strategic Partnerships 5.4.2 Long Term Trends 5.5 Strategic Outlook 5.5.1 Competitive Elements of Mammography Markets 5.5.2 Higher Reimbursement Rates 5.5.3 Volume Requirements 5.5.4 Product Innovation 5.5.5 Product Leadership 5.5.6 Product Line Strategy 5.5.7 Pricing Strategy & Reimbursement 5.5.8 Strategic Partnerships 5.6 Film-Based Mammography Market 5.6.1 Market Overview 188.8.131.52 Unit and Revenue Forecasts 184.108.40.206 Product Analysis 5.6.2 Market Drivers 5.6.3 Market Restraints 5.6.4 Film-Based Mammography Market and Technology Trends 5.6.5 U.S. Market for Film-Based Screening Systems 220.127.116.11 Unit Shipment and Revenue Forecasts 18.104.22.168 Competitive Analysis 22.214.171.124 U.S. Installed Base Analysis 5.6.6 European Market for Film-Based Mammography Systems 126.96.36.199 Unit Shipment and Revenue Forecasts 188.8.131.52 Competitive Analysis 184.108.40.206 Installed Base Analysis 5.6.7 Japanese (Pacific Rim) Market for Film-based Mammography Systems 220.127.116.11 Competitive Analysis 18.104.22.168 Installed Base Analysis 5.6.8 Rest of the World Market for Film-based Mammography Systems 22.214.171.124 Unit Shipment and Revenue Forecasts 126.96.36.199 Installed Base Analysis 5.7 Digital X-Ray Mammography Market 5.7.1 Digital Mammography Overview 5.7.2 Market Overview 5.7.3 Product Background 5.7.4 Product Description 5.7.5 Market Drivers 5.7.6 Market Restraints 5.7.7 Unit Shipment and Revenue Forecasts 5.7.8 Percentage Breakdown of Revenues by Region 5.7.9 Market Share 5.7.10 U.S. Market for Digital Mammography Systems 188.8.131.52 U.S. Sales 184.108.40.206 Competitive Analysis 5.7.11 European Market for Digital Mammography Systems 220.127.116.11 Unit Shipment and Revenue Forecasts 18.104.22.168 Competitive Analysis 22.214.171.124 Installed Base Analysis 5.7.12 Japanese (Pacific Rim) Market for Digital Mammography Systems 126.96.36.199 Unit Shipment and Revenue Forecasts 188.8.131.52 Competitive Analysis 184.108.40.206 Installed Base Analysis 6.0 Women's Health Testing: Growth Regulators 6.1 Moderators of Growth 6.2 Personnel Acceptance 6.3 Key People for Women's Health Testing 6.4 Key Elements for Women's Health Testing 6.5 Women's Health Testing and Reimbursement 6.6 Rapid Near-Patient Testing in Hospitals 6.7 Satellite Facilities 6.8 Regionalization of Laboratory Care 6.9 Requirements for Women's Health Testing 6.10 Clinical Laboratory Improvement Act of 1988 (CLIA) 7.0 Business Trends in the Industry 7.1 Sector Consolidation 7.2 Diagnostic Testing Growth Trends 7.3 Acquisition, License Agreements, Internal Development and Partnerships 7.4 Product Testing Depth in Women's Health Testing 7.5 Government Regulation 7.5.1 U.S. Regulation 220.127.116.11 Importing Medical Devices into the U.S. 18.104.22.168 Exporting Medical Devices from the U.S. 7.5.2 U.K. Regulation 7.5.3 E.U. Regulation 7.5.4 Japanese Regulation 7.6 Increased Market Penetration 7.7 Legal Issues 8.0 Important Technology Trends 9.0 Company Profiles 9.1 Abbott Diagnostics 9.2 Accurex Biomedical, Pvt., Ltd 9.3 Adeza Biomedical Corporation (Acquired by Hologic) 9.4 Agfa-Gevaert Corporation 9.5 Ambri Ltd. 9.6 American Biomedica Corp. 9.7 Avitar Inc. 9.8 Axis-Shield 9.9 Bayer Corporation Diagnostics Division (Acquired by Siemens) 9.10 Becton Dickinson 9.11 Biomerica 9.12 Carestream Health 9.13 CMT Medical Systems 9.14 Cozart Biosciences (Acquired by Concateno PLC) 9.15 Cytyc Corporation 9.16 Dalsa 9.17 Denka Seiken Co., Ltd. 9.18 DiaDexus LLC 9.19 Enterix, Inc. (Acquired by Quest Diagnostics) 9.20 Fischer Imaging (Acquired by Hologic) 9.21 FujiFilm Medical Systems 9.22 General Electric Healthcare 9.23 Genzyme Diagnostics 9.24 Hologic Inc. 9.25 iCAD, Inc. 9.26 Imaging Diagnostic Systems Inc. 9.27 Inverness Medical Innovations 9.28 Johnson & Johnson 9.29 Kyowa Medex Co., Ltd. 9.30 L-3 Titan Group 9.31 LifePoint, Inc. 9.32 LifeScan Corporation 9.33 Matritech 9.34 Medix Biochemica 9.35 Mitsubishi Kagaku Iatron 9.36 Myraid Genetics 9.37 OraSure Technologies, Inc. 9.38 Polymedco 9.39 Procrea 9.40 QIAGEN 9.41 Quidel 9.42 Rad-Icon Imaging Corp 9.43 Roche Diagnostics 9.44 Scanis Inc. 9.45 Sectra Imtec AB 9.46 Shanghai Kehua Bioengineering Co., Ltd. 9.47 Siemens Healthcare 9.48 TriPath Imaging (Acquired by BD) 9.49 Vidar Systems Corp. 10.0 Appendices 10.1 Digital Database for Screening Mammography (DDSM) 10.2 Sources of National Cancer Institute Information 10.3 Screening Mammograms: Questions and Answers 10.4 FDA Rule: State Certification of Mammography Facilities INDEX OF TABLES Table 2.1: Worldwide Market Share In Vitro Diagnostic Companies Table 2.2: Worldwide In Vitro Diagnostics Market Size, 2001-2012 Table 2.3: Worldwide In Vitro Clinical Laboratory Diagnostic Testing 2003-2012 Table 2.4: Worldwide Point-of-Care Diagnostic Testing 2001-2012 Table 3.1: Top Drugstore Retailers in the U.S. Table 3.2: Top Drugstore Wholesalers in the U.S. Table 3.3: U.S. Women's Health Diagnostics Products Market Sales 2000-2012 Table 3.4: U.S. Clinical Diagnostic Women's Test Market Segments 2005 Table 3.5: Regional Comparison Healthcare and IVD Table 3.6: European Women's Care Testing Market, 2000-2012 Table 3.7: European Women's Care Testing Diagnostics Market Table 3.8: German Women's Care Testing Diagnostics Products Market Sales, 2000-2012 Table 3.9: The German Patient Care Laboratory Test Market, 2000-2012 Table 3.10: The German Alternate Site Testing Market, 2000-2012 Table 3.11: The German Hospital Point of Care Market, 2000-2012 Table 3.12: German Clinical Diagnostic Rapid Women's Test Market SegmentsTable 3.13: U.K. Women's Health Diagnostics Products Market Sales, 2006-2012 Table 3.14: Major U.K. IVD Manufacturers Table 3.15: U.S. IVD Manufacturers Doing Business in the U.K. Table 3.16: Other European Companies that Manufacture IVD Products in the United Kingdom Table 3.17: French Women's Health Diagnostics Products Market Sales, 2000-2012 Table 3.18: Italian Women's Health Diagnostics Products Market Sales, 2000-2012 Table 3.19: Spanish Women's Heath Diagnostics Products Market Sales, 2000-2012 Table 3.20: Japan Women's Care Testing Market, 2000-2012 Table 3.21: Chinese Women's Care Diagnostics Products Market Sales, 2000-2012 Table 3.22: The ROW Women's Care Testing Market, 2000-2012 Table 4.1: U.S. Women's Health Testing Pregnancy Testing Market, 2001-2012 Table 4.2: U.S. Market Share for Rapid Women's Health Testing Pregnancy Tests Table 4.3: The Pregnancy Test Market for OTC Testing in the U.S., 2000-2012 Table 4.4: Home Pregnancy Tests Available in the U.S. Market Table 4.5: Osteoporosis Risk Factors that Cannot Be Changed Table 4.6: Osteoporosis Risk Factors that Can Be Changed Table 4.7: Prenatal Screening Types Table 4.8: History: Parental Genetic Traits Table 4.9: Female Factor Infertility Table 4.10: Frequency of Mutation Based Upon Ethnicity Table 4.11: Reasons for CF Testing Table 4.12: CF Testing Methodology Table 4.13: CF Gene Detection Rates Vary by Ethnic Background Table 4.14: Global Market for CF Diagnostic Testing, 2000-2012 Table 4.15: U.S. Market for CF Diagnostic Testing, 2000-2012 Table 4.16: Commercial CF Screening Products Table 4.17: Emerging CF Screening Products Table 4.18: CF Screening Technology Summary Table 4.19: Genetic Screening During Pregnancy Table 4.20: Ultrasound Screening Table 4.21: Future Trends in Prenatal Genetic Testing, 2000-2012 Table 4.22: Ovulation Predictors Table 4.23: TPA Marker Sensitivity Table 4.24: HPV Risk Factors Table 4.25: Relationship between HPV and Cervical Carcinoma Table 4.26: HPV and Cervical Carcinoma Risk Table 4.27: Rationale for Reflex HPV Testing with Cytology Table 4.28: Rationale against Reflex HPV Testing with Cytology Table 4.29: Predictability of HPV Test by Abnormal Pap Smear Type Table 4.30: Incidence of Cervical Cancer and Cytological Abnormalitie Table 4.31: Long Term Trends in HPV Testing Table 4.32: U.S. Women's Health Testing Market for HIV, 2001-2012 Table 4.33: Countries with the Highest Prevalence of HIV / AIDS Table 4.34: Births of HIV Infected Babies in U.S., 2002-2006 Table 4.35: U.S. Strep Testing Market Size, 2002-2012 Table 4.36: U.S. Market for Rapid Point of Care Strep Tests Table 4.37: The U.S. Chlamydia Testing Market, 2000-2012 Table 4.38: Summary of Hepatitis Test Technology Table 5.1: U.S. Healthcare Expenditures, 2000-2010 Table 5.2: International Per Capita Healthcare Spending by Country, 2006 Table 5.3: U.S. Use of Mammography in Women Over 40, 1987-2005 Table 5.4: Annual Mammography Procedures in the U.S., 2000-2008 Table 5.5: Annual Mammography Procedures in Europe, 2002-2007 Table 5.6: Annual Mammography Procedures in Japan, 2002-2007 Table 5.7: Annual Mammography Procedures in the Rest of the World, 2002-2007 Table 5.8: U.S. Mammography Facts, 2005 Table 5.9: Breast Cancer Survival Rates by Country Table 5.10: Surgical Biopsies Performed in the U.S., 2000-2007 Table 5.11: The Worldwide Mammography Instrument Market, 2000-2010 Table 5.12: Worldwide Mammography Instrumentation Placements, 2002-2010 Table 5.13: Worldwide Film-Based Mammography Instrumentation Placements, 2002-2010 Table 5.14: Worldwide Mammography Film-Based Instrument Market, 2000-2010 Table 5.15: Worldwide Mammography Film-Based Instrument Market by Region, 2000-2010 Table 5.16: U.S. Mammography Film-Based Instrument Market, 2000-2010 Table 5.17: U.S. Mammography Film-Based Instrument Market Manufacturer Share Table 5.18: U.S. Film-Based Mammography Instrumentation Placements, 2002-2010 Table 5.19: European Mammography Film-Based Instrument Market, 2000-2010 Table 5.20: European Film-Based Mammography Instrumentation Placements, 2002-2010 Table 5.21: European Mammography Film-Based Instrument Market Manufacturer Share Table 5.22: Japanese Mammography Film-Based Instrument Market, 2000-2010 Table 5.23: Japanese Film-Based Mammography Instrumentation Placements, 2002-2010 Table 5.24: Japanese Mammography Film-Based Instrument Market Manufacturer Share Table 5.25: ROW Mammography Film-Based Instrument Market, 2000-2010 Table 5.26: ROW Film-Based Mammography Instrumentation Placements, 2002-2010 Table 5.27: Advantages of Digital Mammography Table 5.28: Worldwide Digital General Radiography Market, 2000-2012 Table 5.29: Worldwide Market for Digital Mammography Systems Annual Unit Sales, 2000-2010 Table 5.30: Worldwide Market for Digital Mammography Systems, 2000-2010 Table 5.31: Worldwide Mammography Digital Instrumentation Placements, 2002-2010 Table 5.32: Worldwide Mammography Digital Instrument Market by Region, 2001-2010 Table 5.33: Share of Worldwide Market for Digital Mammography Systems by Competitor Table 5.34: U.S. Mammography Digital Instrument Market, 2001-2010 Table 5.35: U.S. Digital Mammography Instrumentation Placements, 2002-2010 Table 5.36: European Mammography Digital Instrument Market, 2001-2010 Table 5.37: European Digital Mammography Instrumentation Placements, 2002-2010 Table 5.38: Japanese Mammography Digital Instrument Market, 2001-2007 Table 5.39: Japanese Digital Mammography Instrumentation Placements, 2002-2010 Table 9.1: Products Marketed By Abbott in the Diagnostic Market
To order this report:
Women’s Health Diagnostic Testing
More market research reports here!
Contacts: Reportlinker.com Nicolas US: (805) 652-2626 or Intl: +1-805-652-2626 Email: firstname.lastname@example.org